NCT07073690Completed
Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China
Real-World Treatment Patterns and Outcomes of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes (LR-MDS) in China ('REACH' Study)
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate the treatment patterns and clinical outcomes in adults with lower-risk MDS (LR-MDS) who were erythropoiesis-stimulating agents (ESA)-naïve and received luspatercept treatment in China
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 88 (actual)
- First submitted
- 10 Jul 2025
- Start date
- 18 Apr 2025
- Primary completion date
- 12 May 2026
- Lead sponsor
- Bristol-Myers Squibb
- Diseases
- Myelodysplastic syndromes
- NCT number
- NCT07073690
What you commit to
- Study type: Observational
- Participants enrolled: 88
- From 18 Apr 2025 to the primary completion date, 12 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Had a history of acute myeloid leukemia (AML) prior to MDS diagnosis.
- Received stem cell transplant prior to luspatercept treatment initiation.
Who the study is looking for
- Participants ≥ 18 years of age.
- Documented diagnosis of no del(5q) MDS that meets lower-risk Myelodysplastic Syndromes (MDS) classification. (Diagnosis criteria and risk classification criteria are based on clinical practice)
- Patients who were erythropoiesis-stimulating agent (ESA)-naïve have received luspatercept monotherapy at least 2 cycles regardless of RS status.
- Historical documentation of anemia before luspatercept treatment.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zhijian Xiao Coordinator of this site? Confirm its status | Tianjin | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.